—EQR
— • —
$61.14
P/E
21.30
PEG
0.03
FCF Yield
—
Rev Growth YoY
+382.0% YoY
Gross Margin
6288.0%
Health Score
4/10
D/E Ratio
0.75
Confidence
LOW
Business Snapshot
The ticker and sector identifiers in this data payload are absent, which limits contextual framing. Based on the available financial data, this appears to be a company with extraordinarily high reported margins and rapid revenue growth, suggesting a possible financial services, royalty, or asset-light business model. The market capitalisation figure is not available, making cap-tier classification impossible from this data alone.
Financial Health
**Score: 4/10** The financial picture here is deeply contradictory. On the surface, margins appear extraordinary — a gross margin of 6,288% and a net margin of 3,620% are not plausible for any conventional operating business and raise immediate questions about data integrity or an unusual corporate structure (e.g., royalty income, asset revaluation, or one-time accounting events)...
Risk Assessment
- **LIQUIDITY:** Current ratio of 0.06x is critically low, indicating the company may struggle to meet short-term obligations with available liquid assets. - **DATA INTEGRITY:** Gross margin of 6,288% and net margin of 3,620% are statistically implausible for a standard operating business and may indicate accounting anomalies, restatements, or a highly unusual corporate structure. - **VALUATION CONFLICT:** EV/EBITDA of 58.53x is sharply elevated while P/E of 21.3x appears moderate — an internal contradiction that warrants deeper investigation before any position sizing. - **TECHNICAL DETERIORATION:** A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates negative price momentum. - **ANALYST CAUTION:** Only 40% of covering analysts rate the stock a Buy, with 60% on Hold — a lack of conviction from sell-side professionals that typically signals elevated uncertainty or known fundamental concerns. ---...